SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-16-017191
Filing Date
2016-04-29
Accepted
2016-04-29 16:36:36
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A srpt-10ka_20151231.htm 10-K/A 2003556
2 EX-31.1 srpt-ex311_9.htm EX-31.1 6413
3 EX-31.2 srpt-ex312_8.htm EX-31.2 6331
4 GRAPHIC g1vklilqu5sv000002.jpg GRAPHIC 12668
5 GRAPHIC g1vklilqu5sv000001.jpg GRAPHIC 17153
  Complete submission text file 0001564590-16-017191.txt   2058983
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-14895 | Film No.: 161607284
SIC: 2834 Pharmaceutical Preparations